Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 31;14:1279–1294. doi: 10.2147/DDDT.S229145

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Effects of DG treatment on performance in behavioral tests. (A) The number of entries in the central area in the open field test (OFT). (B) The distance traveled in the central area in the OFT. (C) Immobility time in the tail suspension test (TST). (D) Immobility time in the forced swimming test (FST). (E) The percentage of time spent in the closed arm in the elevated plus-maze (EPM). (F) The percent alternation in the Y-maze test after 4 weeks of DG treatment. Values represent the mean ± SEM (n = 15 rats per group). *p < 0.05, ns = not significant, compared with the control (CON) group.